Rachel Dockry

P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study

Gary Layton, J. Smith, A. Ford, 2015, The Lancet.

P159 Validation of the VitaloJAK™ 24 Hour Ambulatory Cough Monitor

Kevin McGuinness, K. Mcguinness, Rachel Dockry, 2012, Thorax.

Predictors of objective cough frequency in chronic obstructive pulmonary disease.

Ashley Woodcock, J. Smith, A. Woodcock, 2013, American journal of respiratory and critical care medicine.

Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study

Ashley Woodcock, A. Woodcock, Dave Singh, 2012, Respiratory Research.

Exhaled Volatile Organic Compounds As Potential Biomarkers In Chronic Obstructive Pulmonary Disease

Ruth Tal-Singer, Stephen J. Fowler, Ashley Woodcock, 2010, ATS 2010.